Agitation in Alzheimer disease is not limited to the later stages, geriatric psychiatrist George Grossberg, MD, explains; look for it across the spectrum.
Neuropsychiatric behaviors, and particularly symptoms of agitation, are seen among among individuals with even mild cognitive impairment due to Alzheimer disease (AD), the earliest stage and a period in the arc of the dementia that isn't typically associated with behavioral symptoms. In a recent interview on AD, George Grossberg, MD, a geriatric psychiatrist and researcher active in looking for new therapies for neurocognitive disorders, told Patient Care that recognizing the disruptive behaviors in less severe stages reflects a still evolving understanding of the disease spectrum. Agitated-type behaviors "do become more common with disease progression, but we need to look for them throughout," Grossberg said.
In the short video above, Grossberg discusses the more traditional perspective on agitation in AD and why it is important to look beyond that.
George T Grossberg, MD, is the Samuel W. Fordyce professor and director of Geriatric Psychiatry in the Department of Psychiatry at Saint Louis University School of Medicine. He is a past president of the American Association for Geriatric Psychiatry and of the International Psychogeriatric Association. Grossberg's research focus includes behavioral symptoms in Alzheimer disease and novel therapies for neurocognitive disorders.
The CMS CED Policy Limits Treatment for Early Alzheimer's Disease: What It Is and How It Works
December 16th 2024The coverage with evidence development (CED) policy requires enrollment in an active clinical trial for an adult to be eligible for Medicare coverage of treatment for Alzheimer's disease.